Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
Kholoud N Al-ShafaiMohammed Al-HashemiChidambaram ManickamRania MusaSenthil SelvarajNajeeb SyedFazulur Rehaman VempalliMuneera AliMagdi H YacoubXavier EstivilPublished in: Molecular genetics & genomic medicine (2021)
We identified or replicated at least four recurrent variants among cardiomyopathy patients, which could be founder disease mutations in the Arabic population, including a frameshift variant (c.1371_1381dupTATCCAGTTAT) of unknown significance in the FKTN gene which seems to cause DCM in homozygosity, and HCM in heterozygosity. In vivo and/or in vitro functional validation need to be pursued in order to assess the pathogenicity of the identified variants.
Keyphrases
- copy number
- genome wide
- end stage renal disease
- dna methylation
- ejection fraction
- newly diagnosed
- chronic kidney disease
- heart failure
- peritoneal dialysis
- prognostic factors
- gene expression
- biofilm formation
- patient reported outcomes
- escherichia coli
- cystic fibrosis
- transcription factor
- staphylococcus aureus
- atrial fibrillation
- clinical evaluation